ロード中...

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Interstitial lung disease (ILD) is the primary cause of death in patients with systemic sclerosis (SSc). It is thought that chronic inflammation is a key component in SSc-ILD. Treatment, such as cyclophosphamide (CYC), targets this inflammation. We hypothesized that treatment with CYC might be more...

詳細記述

保存先:
書誌詳細
出版年:Clin Rheumatol
主要な著者: van den Hombergh, W. M. T., Simons, S. O., Teesselink, E., Knaapen-Hans, H. K. A., van den Hoogen, F. H. J., Fransen, J., Vonk, M. C.
フォーマット: Artigo
言語:Inglês
出版事項: Springer London 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154086/
https://ncbi.nlm.nih.gov/pubmed/29987427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-018-4171-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!